Davriellelouna@lemmy.world to News@lemmy.world · 2 days ago‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.comexternal-linkmessage-square67linkfedilinkarrow-up1557arrow-down13cross-posted to: [email protected][email protected]
arrow-up1554arrow-down1external-link‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.comDavriellelouna@lemmy.world to News@lemmy.world · 2 days agomessage-square67linkfedilinkcross-posted to: [email protected][email protected]
minus-squaregravitas_deficiency@sh.itjust.workslinkfedilinkEnglisharrow-up81·2 days agoPharma C-suite: that doesn’t sound very profitable I fucking wish I was kidding
minus-square𝔼𝕩𝕦𝕤𝕚𝕒@lemmy.worldlinkfedilinkarrow-up9·2 days ago“But how does this expand shareholder value”
minus-squarejonne@infosec.publinkfedilinkarrow-up4arrow-down3·2 days agoI mean, it doesn’t actually end it, to have to keep taking their pill. It’s a subscription model to life.
minus-squarejeffw@lemmy.worldMlinkfedilinkarrow-up14arrow-down1·2 days ago Pill You could read the article before you comment lol
Pharma C-suite:
I fucking wish I was kidding
“But how does this expand shareholder value”
I mean, it doesn’t actually end it, to have to keep taking their pill. It’s a subscription model to life.
You could read the article before you comment lol
You caught me!